In conjunction, we believe that IgM level quantification has the potential to distinguish patients with suspected sepsis as probable SIRS patients within a CN cohort (false-positives) and emphasizes the need for more sensitive tests for occlusive organisms potentially undetected in the CN patients (false-negatives). This evidence concerns the gene CD40LG and systemic inflammatory response syndrome.